Biofilms and host response – helpful or harmful
暂无分享,去创建一个
N. Høiby | C. Moser | C. Lerche | K. Thomsen | M. Kolpen | Laura Line | P. Ø. Jensen | Hannah Trøstrup Pedersen
[1] D. Hartl,et al. Pseudomonas aeruginosa Airway Infection Recruits and Modulates Neutrophilic Myeloid-Derived Suppressor Cells , 2016, Front. Cell. Infect. Microbiol..
[2] N. Høiby,et al. Animal models of chronic wound care: the application of biofilms in clinical research , 2016 .
[3] E. Pretorius,et al. Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity , 2016, Scientific Reports.
[4] N. Høiby,et al. Activation of pulmonary and lymph node dendritic cells during chronic Pseudomonas aeruginosa lung infection in mice , 2016, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[5] N. Høiby,et al. The phagocytic fitness of leucopatches may impact the healing of chronic wounds , 2016, Clinical and experimental immunology.
[6] A. Schmidtchen,et al. Pseudomonas aeruginosa elastase cleaves a C-terminal peptide from human thrombin that inhibits host inflammatory responses , 2016, Nature Communications.
[7] N. Borregaard,et al. Neutrophil extracellular traps - the dark side of neutrophils. , 2016, The Journal of clinical investigation.
[8] N. Høiby,et al. S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus , 2016, Archives of Dermatological Research.
[9] P. D. de Groot,et al. Shear-Resistant Binding to von Willebrand Factor Allows Staphylococcus lugdunensis to Adhere to the Cardiac Valves and Initiate Endocarditis. , 2016, The Journal of infectious diseases.
[10] M. Balaan,et al. Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.
[11] E. Bruscia,et al. Innate and Adaptive Immunity in Cystic Fibrosis. , 2016, Clinics in chest medicine.
[12] K. Timmis,et al. Protein Network of the Pseudomonas aeruginosa Denitrification Apparatus , 2016, Journal of bacteriology.
[13] H. Bundgaard,et al. Low efficacy of tobramycin in experimental Staphylococcus aureus endocarditis , 2015, European Journal of Clinical Microbiology & Infectious Diseases.
[14] A. Oliver,et al. ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[15] J. McGuire. Regulatory T cells in cystic fibrosis lung disease. More answers, more questions. , 2015, American journal of respiratory and critical care medicine.
[16] M. Hogardt,et al. Regulatory T-cell impairment in cystic fibrosis patients with chronic pseudomonas infection. , 2015, American journal of respiratory and critical care medicine.
[17] Chii‐Ming Lee,et al. Endocarditis Pathogen Promotes Vegetation Formation by Inducing Intravascular Neutrophil Extracellular Traps Through Activated Platelets , 2015, Circulation.
[18] M. Kühl,et al. Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum , 2014, Front. Microbiol..
[19] G. Drusano,et al. Interaction of drug- and granulocyte-mediated killing of Pseudomonas aeruginosa in a murine pneumonia model. , 2014, The Journal of infectious diseases.
[20] T. Scheike,et al. Polymorphonuclear Leukocytes Restrict Growth of Pseudomonas aeruginosa in the Lungs of Cystic Fibrosis Patients , 2014, Infection and Immunity.
[21] C. Hansen,et al. Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen , 2014, Clinical and experimental immunology.
[22] N. Høiby,et al. Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[23] S. Bicknell,et al. T Helper Cell Subsets Specific for Pseudomonas aeruginosa in Healthy Individuals and Patients with Cystic Fibrosis , 2014, PloS one.
[24] S. Uchiyama,et al. Increased Neutrophil Extracellular Trap–Mediated Staphylococcus aureus Clearance Through Inhibition of Nuclease Activity by Clindamycin and Immunoglobulin , 2014, The Journal of infectious diseases.
[25] A. Kharazmi,et al. Nitrous Oxide Production in Sputum from Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Lung Infection , 2014, PloS one.
[26] R. Nemenoff,et al. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. , 2014, Immunity.
[27] A. Bahar,et al. Antimicrobial Peptides , 2013, Pharmaceuticals.
[28] S. Bell,et al. Sputum neutrophils in cystic fibrosis patients display a reduced respiratory burst. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[29] D. Raoult,et al. Immunoglobulin G anticardiolipin antibodies and progression to Q fever endocarditis. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] B. Iung,et al. Prevalence of anti-neutrophil cytoplasmic antibodies in infective endocarditis: An analysis of 109 cases , 2013 .
[31] C. Akdis,et al. A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. , 2013, American journal of respiratory and critical care medicine.
[32] L. Louedec,et al. Predominant Role of Host Proteases in Myocardial Damage Associated with Infectious Endocarditis Induced by Enterococcus faecalis in a Rat Model , 2013, Infection and Immunity.
[33] N. Høiby,et al. Pseudomonas aeruginosa biofilm aggravates skin inflammatory response in BALB/c mice in a novel chronic wound model , 2013, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[34] M. Hogardt,et al. Flagellin Induces Myeloid-Derived Suppressor Cells: Implications for Pseudomonas aeruginosa Infection in Cystic Fibrosis Lung Disease , 2013, The Journal of Immunology.
[35] S. Sagel,et al. Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis. , 2012, American journal of respiratory and critical care medicine.
[36] J. Elborn,et al. Treatment of lung infection in patients with cystic fibrosis: current and future strategies. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[37] N. Al-Attar,et al. Role of Vegetation-Associated Protease Activity in Valve Destruction in Human Infective Endocarditis , 2012, PLoS ONE.
[38] K. Tracey,et al. Alarmins: awaiting a clinical response. , 2012, The Journal of clinical investigation.
[39] N. Høiby,et al. Interactions between Polymorphonuclear Leukocytes and Pseudomonas aeruginosa Biofilms on Silicone Implants In Vivo , 2012, Infection and Immunity.
[40] C. Shun,et al. Platelets enhance biofilm formation and resistance of endocarditis-inducing streptococci on the injured heart valve. , 2012, The Journal of infectious diseases.
[41] R. Kronmal,et al. Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis , 2012, Pediatric pulmonology.
[42] R. Gallo,et al. Antimicrobial peptides: Old Molecules with New Ideas , 2011, The Journal of investigative dermatology.
[43] T. Karlsmark,et al. A Pilot Study to Evaluate the Safety and Clinical Performance of Leucopatch, an Autologous, Additive-Free, Platelet-Rich Fibrin for the Treatment of Recalcitrant Chronic Wounds , 2011, The international journal of lower extremity wounds.
[44] L. Jørgensen,et al. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling , 2011, The British journal of dermatology.
[45] T. Bjarnsholt,et al. Success Rate of Split-Thickness Skin Grafting of Chronic Venous Leg Ulcers Depends on the Presence of Pseudomonas aeruginosa: A Retrospective Study , 2011, PloS one.
[46] T. Tolker-Nielsen,et al. Quantitative analysis of the cellular inflammatory response against biofilm bacteria in chronic wounds , 2011, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[47] S. Molin,et al. The clinical impact of bacterial biofilms , 2011, International Journal of Oral Science.
[48] M. Surette,et al. A Novel Mechanism of Rapid Nuclear Neutrophil Extracellular Trap Formation in Response to Staphylococcus aureus , 2010, The Journal of Immunology.
[49] L. Dupont,et al. Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients , 2010, Respiratory research.
[50] M. Givskov,et al. The immune system vs. Pseudomonas aeruginosa biofilms. , 2010, FEMS immunology and medical microbiology.
[51] A. Watson,et al. Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis , 2010, Thorax.
[52] M. Kruhlak,et al. Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents. , 2010, The Journal of infectious diseases.
[53] G. Drusano,et al. Impact of Burden on Granulocyte Clearance of Bacteria in a Mouse Thigh Infection Model , 2010, Antimicrobial Agents and Chemotherapy.
[54] D. Tambourgi,et al. IgY: A promising antibody for use in immunodiagnostic and in immunotherapy , 2010, Veterinary Immunology and Immunopathology.
[55] S. Molin,et al. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa. , 2009, The Journal of antimicrobial chemotherapy.
[56] M. Parsek,et al. Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. , 2009, Microbiology.
[57] A. Kharazmi,et al. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis , 2009, Thorax.
[58] A. Cowburn,et al. Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation , 2009, European Respiratory Journal.
[59] A. Kharazmi,et al. Effect of Pseudomonas aeruginosa proteases on human leukocyte phagocytosis and bactericidal activity. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology.
[60] Emily K. Cope,et al. Flagellum-Mediated Biofilm Defense Mechanisms of Pseudomonas aeruginosa against Host-Derived Lactoferrin , 2009, Infection and Immunity.
[61] J. Costerton,et al. Periodontitis: an archetypical biofilm disease. , 2009, Journal of the American Dental Association.
[62] T. Byrd,et al. Mycobacterium abscessus Glycopeptidolipids Mask Underlying Cell Wall Phosphatidyl-myo-Inositol Mannosides Blocking Induction of Human Macrophage TNF-α by Preventing Interaction with TLR21 , 2009, The Journal of Immunology.
[63] N. Høiby,et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients , 2009, Pediatric pulmonology.
[64] D. Littman,et al. Plasticity of CD4+ T cell lineage differentiation. , 2009, Immunity.
[65] S. Diggle,et al. Pseudomonas aeruginosa quorum-sensing signal molecules interfere with dendritic cell-induced T-cell proliferation. , 2009, FEMS immunology and medical microbiology.
[66] N. Høiby,et al. Thermal injury induces impaired function in polymorphonuclear neutrophil granulocytes and reduced control of burn wound infection , 2009, Clinical and experimental immunology.
[67] K. Malcolm,et al. Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy , 2009, Journal of medical microbiology.
[68] J. Fraile,et al. Endocarditis Caused by Staphylococcus aureus: A Reappraisal of the Epidemiologic, Clinical, and Pathologic Manifestations With Analysis of Factors Determining Outcome , 2009, Medicine.
[69] N. Høiby,et al. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. , 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[70] J. Elborn,et al. Neutrophils in cystic fibrosis , 2008, Thorax.
[71] A. Larsson,et al. Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients , 2008, Pediatric pulmonology.
[72] A. Gaggar,et al. TLR Expression on Neutrophils at the Pulmonary Site of Infection: TLR1/TLR2-Mediated Up-Regulation of TLR5 Expression in Cystic Fibrosis Lung Disease1 , 2008, The Journal of Immunology.
[73] S. Kaufmann. Immunology's foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff , 2008, Nature Immunology.
[74] C. Nathan. Metchnikoff's Legacy in 2008 , 2008, Nature Immunology.
[75] T. Tolker-Nielsen,et al. Distribution, Organization, and Ecology of Bacteria in Chronic Wounds , 2008, Journal of Clinical Microbiology.
[76] Á. Zorreguieta,et al. Characterization of bacterial DNA binding to human neutrophil surface , 2008, Laboratory Investigation.
[77] M. Stacey,et al. Induction of MMP‐1, MMP‐3 and TIMP‐1 in normal dermal fibroblasts by chronic venous leg ulcer wound fluid * , 2008, International wound journal.
[78] D. Littman,et al. Transcriptional regulation of Th17 cell differentiation. , 2007, Seminars in immunology.
[79] M. Veldhoen,et al. Th17 T cells: linking innate and adaptive immunity. , 2007, Seminars in immunology.
[80] D. Wozniak,et al. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. , 2007, Current opinion in microbiology.
[81] B. Wretlind,et al. Pseudomonas aeruginosa infections are prevented in cystic fibrosis patients by avian antibodies binding Pseudomonas aeruginosa flagellin. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[82] R. Ramphal,et al. The role of flagellin versus motility in acute lung disease caused by Pseudomonas aeruginosa. , 2007, The Journal of infectious diseases.
[83] C. Harwood,et al. Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration , 2007, Molecular microbiology.
[84] F. Locatelli,et al. Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. , 2007, Blood.
[85] K. Dybvig,et al. Biofilms Protect Mycoplasma pulmonis Cells from Lytic Effects of Complement and Gramicidin , 2007, Infection and Immunity.
[86] P. Williams,et al. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. , 2007, Microbiology.
[87] T. Foster,et al. Both Complement- and Fibrinogen-Dependent Mechanisms Contribute to Platelet Aggregation Mediated by Staphylococcus aureus Clumping Factor B , 2007, Infection and Immunity.
[88] R. Kronmal,et al. Association between pulmonary function and sputum biomarkers in cystic fibrosis. , 2007, American journal of respiratory and critical care medicine.
[89] Stephen R. Clark,et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood , 2007, Nature Medicine.
[90] Stacie A. Brown,et al. Membrane-Bound Nitrate Reductase Is Required for Anaerobic Growth in Cystic Fibrosis Sputum , 2007, Journal of bacteriology.
[91] S. Zimmermann,et al. Induction of Neutrophil Chemotaxis by the Quorum-Sensing Molecule N-(3-Oxododecanoyl)-l-Homoserine Lactone , 2006, Infection and Immunity.
[92] J. Bass,et al. Neutrophil Signaling Pathways Activated by Bacterial DNA Stimulation1 , 2006, The Journal of Immunology.
[93] A. Kharazmi,et al. Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia. , 2006, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[94] Mark A Mintun,et al. Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. , 2006, American journal of respiratory and critical care medicine.
[95] G. Joos,et al. Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms. , 2006, American journal of respiratory cell and molecular biology.
[96] E. Rietschel,et al. Oxidative changes of bronchoalveolar proteins in cystic fibrosis. , 2006, Chest.
[97] R. Fowler,et al. Subacute and acute infective endocarditis , 2005, The Lancet.
[98] D. Hassett,et al. The Exopolysaccharide Alginate Protects Pseudomonas aeruginosa Biofilm Bacteria from IFN-γ-Mediated Macrophage Killing1 , 2005, The Journal of Immunology.
[99] Massimiliano Mascherini,et al. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients , 2005, European Respiratory Journal.
[100] S. Dower,et al. The expression and roles of Toll‐like receptors in the biology of the human neutrophil , 2005, Journal of leukocyte biology.
[101] K. Malcolm,et al. Enhanced Pseudomonas aeruginosa Biofilm Development Mediated by Human Neutrophils , 2005, Infection and Immunity.
[102] A. Kharazmi,et al. Serum concentrations of GM‐CSF and G‐CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection , 2005, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[103] S. Nasser,et al. Antibiotic allergy in cystic fibrosis , 2005, Thorax.
[104] Patrice François,et al. Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis , 2005, The Journal of experimental medicine.
[105] A. Šedivá,et al. Differential cytokine profile in children with cystic fibrosis. , 2005, Clinical immunology.
[106] W. Zimmerli,et al. Prosthetic joint infections: update in diagnosis and treatment. , 2005, Swiss medical weekly.
[107] S. Molin,et al. Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. , 2005, Microbiology.
[108] Robin Patel,et al. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. , 2004, The American journal of medicine.
[109] A. Kharazmi,et al. Faster activation of polymorphonuclear neutrophils in resistant mice during early innate response to Pseudomonas aeruginosa lung infection , 2004, Clinical and experimental immunology.
[110] P. Cosette,et al. Proteomic analysis of agar gel‐entrapped Pseudomonas aeruginosa , 2004, Proteomics.
[111] J. Davidson,et al. Migration inhibitory factor‐related protein (MRP)8 and MRP14 are differentially expressed in free‐electron laser and scalpel incisions , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[112] P. Gøtzsche,et al. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: A marker of therapeutic success?—A 30‐year Cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection , 2004, Pediatric pulmonology.
[113] R. Gibson,et al. Pathophysiology and management of pulmonary infections in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.
[114] A. Jesaitis,et al. Compromised Host Defense on Pseudomonas aeruginosa Biofilms: Characterization of Neutrophil and Biofilm Interactions 1 , 2003, The Journal of Immunology.
[115] J. Elborn,et al. Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa , 2003, European Respiratory Journal.
[116] L. Adorini,et al. Cutting Edge: Differential Chemokine Production by Myeloid and Plasmacytoid Dendritic Cells1 , 2002, The Journal of Immunology.
[117] S. Akira,et al. Involvement of Toll-like Receptor (TLR) 2 and TLR4 in Cell Activation by Mannuronic Acid Polymers* , 2002, The Journal of Biological Chemistry.
[118] E. Greenberg,et al. A component of innate immunity prevents bacterial biofilm development , 2002, Nature.
[119] J. Costerton,et al. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.
[120] M. Knowles,et al. Mucus clearance as a primary innate defense mechanism for mammalian airways. , 2002, The Journal of clinical investigation.
[121] J. Mattick,et al. Extracellular DNA required for bacterial biofilm formation. , 2002, Science.
[122] Richard C Boucher,et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.
[123] A. Kharazmi,et al. Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1‐dominated cytokine response , 2002, Clinical and experimental immunology.
[124] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[125] W. Koppenol,et al. Product distribution of peroxynitrite decay as a function of pH, temperature, and concentration. , 2002, Journal of the American Chemical Society.
[126] Antonio Lanzavecchia,et al. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells , 2001, European journal of immunology.
[127] I. Thorey,et al. The Ca2+-binding Proteins S100A8 and S100A9 Are Encoded by Novel Injury-regulated Genes* , 2001, The Journal of Biological Chemistry.
[128] N. Kadowaki,et al. Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens , 2001, The Journal of experimental medicine.
[129] J. Krijgsveld,et al. Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis. , 2001, The Journal of infectious diseases.
[130] Shizhong Xu,et al. Genetic control of the rate of wound healing in mice , 2001, Heredity.
[131] S. Akira,et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 , 2001, Nature.
[132] B. Beutler,et al. The evolution and genetics of innate immunity , 2001, Nature Reviews Genetics.
[133] G. Pier,et al. Role of Alginate O Acetylation in Resistance of Mucoid Pseudomonas aeruginosa to Opsonic Phagocytosis , 2001, Infection and Immunity.
[134] D. Steinberg,et al. The Interactions of Human Neutrophils with the Constituents of an Experimental Dental Biofilm , 2000, Journal of dental research.
[135] M. Grisham,et al. Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum , 2000, Pediatric pulmonology.
[136] R. Moss,et al. Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes , 2000, Clinical and experimental immunology.
[137] N. Klein,et al. Differential binding of mannose-binding lectin to respiratory pathogens in cystic fibrosis , 2000, The Lancet.
[138] A. Kharazmi,et al. The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type , 2000, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[139] D. Wozniak,et al. Negative Control of Flagellum Synthesis in Pseudomonas aeruginosa Is Modulated by the Alternative Sigma Factor AlgT (AlgU) , 1999, Journal of bacteriology.
[140] P. Kalinski,et al. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. , 1999, Immunology today.
[141] S. Molin,et al. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. , 1999, Microbiology.
[142] A. Kharazmi,et al. Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T‐helper cell response , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[143] L. Maltais,et al. Mouse cell surface antigens: nomenclature and immunophenotyping. , 1998, Journal of immunology.
[144] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[145] B. Rubin,et al. Nitric oxide metabolites in cystic fibrosis lung disease , 1998, Archives of disease in childhood.
[146] N. Høiby,et al. Bacterial Endocarditis at a Tertiary Hospital – How Do We Improve Diagnosis and Delay of Treatment? , 1998, Cardiology.
[147] W. Zumft. Cell biology and molecular basis of denitrification. , 1997, Microbiology and molecular biology reviews : MMBR.
[148] A. Cheung,et al. Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins , 1997, Infection and immunity.
[149] M. Yeaman. The role of platelets in antimicrobial host defense. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[150] J. Rygaard,et al. Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice , 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[151] J. Hull,et al. Pulmonary oxidative stress response in young children with cystic fibrosis. , 1997, Thorax.
[152] N. Greenspan,et al. Bispecific antibodies overcome the opsonin-receptor mismatch of cystic fibrosis in vitro: restoration of neutrophil-mediated phagocytosis and killing of Pseudomonas aeruginosa. , 1997, Journal of immunology.
[153] N. Høiby,et al. Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry. , 1996, Thorax.
[154] M. Ghannoum,et al. Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis , 1996, Infection and immunity.
[155] J. Rygaard,et al. Interferon‐gamma (IFN‐γ) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats , 1996, Clinical and experimental immunology.
[156] G. Warr,et al. IgY: clues to the origins of modern antibodies. , 1995, Immunology today.
[157] J. M. Gilbert,et al. Simple method to purify chicken immunoglobulin G. , 1994, Poultry science.
[158] M. Tvede,et al. IgG antibody response in bacterial endocarditis using ELISA with multiple antigens , 1994, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[159] O. Ciofu,et al. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center , 1994, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[160] A. Kharazmi,et al. Complement activation by Pseudomonas aeruginosa biofilms. , 1993, Microbial pathogenesis.
[161] A. Kharazmi,et al. Induction of oxidative burst response in human neutrophils by immune complexes made in vitro of lipopolysaccharide and hyperimmune serum from chronically infected patients , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[162] M. Tvede,et al. Crossed immunoelectrophoresis used for bacteriological diagnosis in patients with endocarditis , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[163] M. Otterlei,et al. Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction , 1993, Infection and immunity.
[164] N. Høiby,et al. Pathogenesis of cystic fibrosis , 1993, The Lancet.
[165] F. Bazzoni,et al. Interferon-gamma inhibits interleukin-8 production by human polymorphonuclear leucocytes. , 1993, Immunology.
[166] M. Meyer,et al. The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis , 1992, Infection and immunity.
[167] Y. Fukumori,et al. A novel terminal oxidase, cytochrome baa3 purified from aerobically grown Pseudomonas aeruginosa: it shows a clear difference between resting state and pulsed state. , 1992, Journal of biochemistry.
[168] K. Matsushima,et al. Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors. , 1991, Blood.
[169] A. Kharazmi,et al. Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa. , 1991, Immunology letters.
[170] A. Kharazmi,et al. Inhibition of human monocyte chemotaxis and chemiluminescence by Pseudomonas aeruginosa elastase , 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[171] A. Kharazmi,et al. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response , 1990, Infection and immunity.
[172] C. Nathan,et al. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins , 1989, The Journal of cell biology.
[173] M. Parmely,et al. Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity , 1988, Infection and immunity.
[174] A. Kharazmi,et al. Modulation of human neutrophil and monocyte chemotaxis and superoxide responses by recombinant TNF-alpha and GM-CSF. , 1988, Immunobiology.
[175] T. Theander,et al. Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases , 1988, Infection and immunity.
[176] A. Kharazmi,et al. Priming of neutrophils for enhanced oxidative burst by sputum from cystic fibrosis patients with Pseudomonas aeruginosa infection , 1987, European journal of clinical investigation.
[177] R. Coffman,et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.
[178] K. Botzenhart,et al. Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis , 1985, Infection and immunity.
[179] A. Kharazmi,et al. Interaction of Pseudomonas aeruginosa alkaline protease and elastase with human polymorphonuclear leukocytes in vitro , 1984, Infection and immunity.
[180] N. Høiby,et al. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis , 1983, Infection and Immunity.
[181] T. Herlin,et al. Energy metabolism of human neutrophils during phagocytosis. , 1982, The Journal of clinical investigation.
[182] K. Matsushita,et al. o‐Type cytochrome oxidase in the membrane of aerobically grown Pseudomonas aeruginosa , 1982, FEBS letters.
[183] M. Høiby,et al. Activated complement in the sputum from patients with cystic fibrosis. , 1979, Acta pathologica et microbiologica Scandinavica. Section C, Immunology.
[184] D. Durack. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions , 1975, The Journal of pathology.
[185] B. Babior,et al. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. , 1973, The Journal of clinical investigation.
[186] D. Durack,et al. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. , 1972, British journal of experimental pathology.
[187] D. Durack,et al. Experimental Bacterial Endocarditis: II. Survival of Bacteria in Endocardial Vegetations , 1972 .
[188] Ralph W. Gerard,et al. THE EXTRA RESPIRATION OF PHAGOCYTOSIS , 1932 .
[189] V. Rousson,et al. Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans? , 2015, The Journal of infectious diseases.
[190] K. Holmstrøm,et al. Characteristics of an autologous leukocyte and platelet‐rich fibrin patch intended for the treatment of recalcitrant wounds , 2013, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[191] Martin Stotz,et al. Lactate in cystic fibrosis sputum. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[192] G. Hänsch,et al. Destruction of bacterial biofilms by polymorphonuclear neutrophils: relative contribution of phagocytosis, DNA release, and degranulation. , 2010, The International journal of artificial organs.
[193] K. Krogfelt,et al. Why chronic wounds will not heal: a novel hypothesis , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[194] J. Calhoun,et al. Osteomyelitis and the role of biofilms in chronic infection. , 2008, FEMS immunology and medical microbiology.
[195] D. Reinhardt,et al. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. , 2006, The Journal of allergy and clinical immunology.
[196] D. Reinhardt,et al. Pulmonary TH2 response in Pseudomonas aeruginosa–infected patients with cystic fibrosis , 2006 .
[197] S. Rennard,et al. Pathogenesis of COPD. , 2003, Clinical cornerstone.
[198] A. Kharazmi,et al. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. , 2001, Microbes and infection.
[199] E. Bouza,et al. Infections caused by Gram-positive bacteria: situation and challenges of treatment. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[200] C Caux,et al. Immunobiology of dendritic cells. , 2000, Annual review of immunology.
[201] S. Padmaja,et al. The reaction of no with superoxide. , 1993, Free radical research communications.
[202] S. Pedersen,et al. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. , 1992, APMIS. Supplementum.
[203] M. Terpenning. Infective endocarditis. , 1992, Clinics in geriatric medicine.
[204] M. Yamada,et al. Membrane-bound respiratory chain of Pseudomonas aeruginosa grown aerobically. A KCN-insensitive alternate oxidase chain and its energetics. , 1983, Journal of biochemistry.
[205] N. Høiby. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. , 1977, Acta pathologica et microbiologica Scandinavica. Supplement.